Pentamidine: a review.
Wispelwey
B
B
Department of Internal Medicine, University of Virginia, Charlottesville 22908.
Pearson
R D
RD
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000280:Administration, Inhalation; D000818:Animals; D006207:Half-Life; D006801:Humans; D008657:Metabolic Clearance Rate; D010419:Pentamidine / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011020:Pneumonia, Pneumocystis / Q000378:metabolism* / Q000517:prevention & control; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination